nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—ABCG2—Dactinomycin—ocular cancer	0.325	0.492	CbGbCtD
Zidovudine—ABCG2—Carboplatin—ocular cancer	0.219	0.331	CbGbCtD
Zidovudine—ABCB1—Dactinomycin—ocular cancer	0.117	0.177	CbGbCtD
Zidovudine—TERT—Signaling by WNT in cancer—HDAC1—ocular cancer	0.00125	0.00371	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—EP300—ocular cancer	0.00125	0.0037	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—RBBP4—ocular cancer	0.00124	0.00367	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—E2F3—ocular cancer	0.00124	0.00367	CbGpPWpGaD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.00124	0.00366	CbGpPWpGaD
Zidovudine—TERT—Regulation of Telomerase—MYC—ocular cancer	0.00123	0.00364	CbGpPWpGaD
Zidovudine—TERT—Regulation of Telomerase—TGFB1—ocular cancer	0.00123	0.00363	CbGpPWpGaD
Zidovudine—TK1—Metabolism—PSPH—ocular cancer	0.00121	0.00357	CbGpPWpGaD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00121	0.00357	CbGpPWpGaD
Zidovudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.0012	0.00354	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDC25A—ocular cancer	0.00118	0.00349	CbGpPWpGaD
Zidovudine—TERT—formation of the beta-catenin:TCF transactivating complex—EP300—ocular cancer	0.00116	0.00343	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TFDP1—ocular cancer	0.00116	0.00341	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—MYC—ocular cancer	0.00109	0.00323	CbGpPWpGaD
Zidovudine—TERT—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00108	0.00319	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CCND3—ocular cancer	0.00105	0.0031	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—ID2—ocular cancer	0.00105	0.00309	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—HDAC1—ocular cancer	0.00103	0.00305	CbGpPWpGaD
Zidovudine—TERT—formation of the beta-catenin:TCF transactivating complex—MYC—ocular cancer	0.00101	0.00299	CbGpPWpGaD
Zidovudine—TK1—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.000991	0.00293	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—CCND1—ocular cancer	0.000903	0.00267	CbGpPWpGaD
Zidovudine—TERT—Validated targets of C-MYC transcriptional activation—TP53—ocular cancer	0.000896	0.00265	CbGpPWpGaD
Zidovudine—TERT—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000874	0.00258	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—CDKN1A—ocular cancer	0.000873	0.00258	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CCND3—ocular cancer	0.000869	0.00257	CbGpPWpGaD
Zidovudine—TERT—Disease—SAG—ocular cancer	0.000865	0.00256	CbGpPWpGaD
Zidovudine—TERT—Regulation of Telomerase—AKT1—ocular cancer	0.000853	0.00252	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—EP300—ocular cancer	0.000831	0.00245	CbGpPWpGaD
Zidovudine—ABCC5—Fluoropyrimidine Activity—TP53—ocular cancer	0.000793	0.00234	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDK6—ocular cancer	0.000781	0.00231	CbGpPWpGaD
Zidovudine—TERT—Disease—E2F5—ocular cancer	0.000765	0.00226	CbGpPWpGaD
Zidovudine—TERT—Disease—E2F4—ocular cancer	0.00075	0.00222	CbGpPWpGaD
Zidovudine—TERT—Disease—RPL39—ocular cancer	0.000735	0.00217	CbGpPWpGaD
Zidovudine—TERT—Disease—RBL1—ocular cancer	0.000735	0.00217	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—MYC—ocular cancer	0.000724	0.00214	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—TGFB1—ocular cancer	0.000722	0.00213	CbGpPWpGaD
Zidovudine—SLC22A7—Fluoropyrimidine Activity—TP53—ocular cancer	0.000682	0.00202	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CCND2—ocular cancer	0.000671	0.00198	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—HDAC1—ocular cancer	0.000671	0.00198	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—ocular cancer	0.000648	0.00191	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—SAG—ocular cancer	0.000606	0.00179	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDKN2B—ocular cancer	0.000602	0.00178	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—TP53—ocular cancer	0.000595	0.00176	CbGpPWpGaD
Zidovudine—TERT—Disease—TFDP1—ocular cancer	0.000593	0.00175	CbGpPWpGaD
Zidovudine—TERT—TCF dependent signaling in response to WNT—EP300—ocular cancer	0.000556	0.00164	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—E2F1—ocular cancer	0.000552	0.00163	CbGpPWpGaD
Zidovudine—ABCG2—HIF-2-alpha transcription factor network—EP300—ocular cancer	0.00055	0.00163	CbGpPWpGaD
Zidovudine—ABCC4—Fluoropyrimidine Activity—TP53—ocular cancer	0.00055	0.00162	CbGpPWpGaD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—EP300—ocular cancer	0.000538	0.00159	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—E2F5—ocular cancer	0.000536	0.00158	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—E2F4—ocular cancer	0.000525	0.00155	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—RBL1—ocular cancer	0.000515	0.00152	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000502	0.00148	CbGpPWpGaD
Zidovudine—TERT—TGF-beta Signaling Pathway—AKT1—ocular cancer	0.000502	0.00148	CbGpPWpGaD
Zidovudine—TERT—Signaling by WNT in cancer—EP300—ocular cancer	0.0005	0.00148	CbGpPWpGaD
Zidovudine—TERT—TCF dependent signaling in response to WNT—MYC—ocular cancer	0.000485	0.00143	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PSPH—ocular cancer	0.000481	0.00142	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDK2—ocular cancer	0.000476	0.00141	CbGpPWpGaD
Zidovudine—TERT—Disease—MAML2—ocular cancer	0.000471	0.00139	CbGpPWpGaD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—MYC—ocular cancer	0.000469	0.00139	CbGpPWpGaD
Zidovudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000468	0.00138	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000467	0.00138	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDK4—ocular cancer	0.00045	0.00133	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—E2F3—ocular cancer	0.000447	0.00132	CbGpPWpGaD
Zidovudine—TERT—Signaling by WNT in cancer—MYC—ocular cancer	0.000436	0.00129	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TFDP1—ocular cancer	0.000415	0.00123	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—EP300—ocular cancer	0.000412	0.00122	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.000409	0.00121	CbGpPWpGaD
Zidovudine—ABCG2—Fluoropyrimidine Activity—TP53—ocular cancer	0.000403	0.00119	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.000401	0.00118	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—RB1—ocular cancer	0.000391	0.00116	CbGpPWpGaD
Zidovudine—ABCC5—Disease—SAG—ocular cancer	0.000381	0.00112	CbGpPWpGaD
Zidovudine—TK1—Metabolism—GNA11—ocular cancer	0.000381	0.00112	CbGpPWpGaD
Zidovudine—CYP2A6—Fluoropyrimidine Activity—TP53—ocular cancer	0.000366	0.00108	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—MYC—ocular cancer	0.000359	0.00106	CbGpPWpGaD
Zidovudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000358	0.00106	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PSPH—ocular cancer	0.000355	0.00105	CbGpPWpGaD
Zidovudine—TK1—Metabolism—GNAQ—ocular cancer	0.000354	0.00105	CbGpPWpGaD
Zidovudine—TERT—Disease—HDAC1—ocular cancer	0.000344	0.00102	CbGpPWpGaD
Zidovudine—ABCC5—Disease—E2F5—ocular cancer	0.000337	0.000996	CbGpPWpGaD
Zidovudine—TERT—TCF dependent signaling in response to WNT—AKT1—ocular cancer	0.000336	0.000993	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MDM2—ocular cancer	0.000334	0.000986	CbGpPWpGaD
Zidovudine—ABCC5—Disease—E2F4—ocular cancer	0.00033	0.000975	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MAML2—ocular cancer	0.00033	0.000974	CbGpPWpGaD
Zidovudine—ABCC4—Platelet degranulation—TGFB1—ocular cancer	0.000329	0.000972	CbGpPWpGaD
Zidovudine—TERT—RNF mutants show enhanced WNT signaling and proliferation—AKT1—ocular cancer	0.000325	0.000961	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RBL1—ocular cancer	0.000324	0.000957	CbGpPWpGaD
Zidovudine—ABCC5—Disease—RPL39—ocular cancer	0.000324	0.000957	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000324	0.000956	CbGpPWpGaD
Zidovudine—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000313	0.000926	CbGpPWpGaD
Zidovudine—TERT—Disease—CDKN2B—ocular cancer	0.000309	0.000912	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDKN1B—ocular cancer	0.000305	0.0009	CbGpPWpGaD
Zidovudine—TERT—Signaling by WNT in cancer—AKT1—ocular cancer	0.000302	0.000893	CbGpPWpGaD
Zidovudine—ABCC5—NRF2 pathway—TGFB1—ocular cancer	0.000293	0.000867	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CCND1—ocular cancer	0.000291	0.000859	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GNA11—ocular cancer	0.000288	0.00085	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—CDKN1A—ocular cancer	0.000281	0.000831	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—EP300—ocular cancer	0.000268	0.000791	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—GNAQ—ocular cancer	0.000267	0.00079	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TFDP1—ocular cancer	0.000261	0.000771	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—GNA11—ocular cancer	0.000259	0.000765	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—ocular cancer	0.000253	0.000747	CbGpPWpGaD
Zidovudine—TERT—Signaling by Wnt—AKT1—ocular cancer	0.000249	0.000736	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PSPH—ocular cancer	0.000245	0.000723	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PSPH—ocular cancer	0.000242	0.000715	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HDAC1—ocular cancer	0.000241	0.000712	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—GNAQ—ocular cancer	0.000241	0.000711	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—MYC—ocular cancer	0.000233	0.000689	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.000227	0.000672	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PSPH—ocular cancer	0.000222	0.000657	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HDAC1—ocular cancer	0.000217	0.000641	CbGpPWpGaD
Zidovudine—UGT2B7—NRF2 pathway—TGFB1—ocular cancer	0.000216	0.000639	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CDKN2B—ocular cancer	0.000216	0.000639	CbGpPWpGaD
Zidovudine—ABCC4—Ectoderm Differentiation—MYC—ocular cancer	0.000213	0.00063	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.000211	0.000624	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MAML2—ocular cancer	0.000207	0.000613	CbGpPWpGaD
Zidovudine—ABCC4—NRF2 pathway—TGFB1—ocular cancer	0.000203	0.000601	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—E2F1—ocular cancer	0.000198	0.000586	CbGpPWpGaD
Zidovudine—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000196	0.000578	CbGpPWpGaD
Zidovudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.000194	0.000572	CbGpPWpGaD
Zidovudine—TERT—Cell Cycle—TP53—ocular cancer	0.000191	0.000566	CbGpPWpGaD
Zidovudine—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.000179	0.00053	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.000175	0.000517	CbGpPWpGaD
Zidovudine—TERT—Disease—MDM2—ocular cancer	0.000171	0.000506	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.000168	0.000497	CbGpPWpGaD
Zidovudine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.000167	0.000493	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—MDM2—ocular cancer	0.000165	0.000486	CbGpPWpGaD
Zidovudine—TERT—Disease—CDKN1B—ocular cancer	0.000156	0.000462	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000154	0.000456	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—CDK2—ocular cancer	0.000154	0.000455	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSPH—ocular cancer	0.000152	0.000449	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HDAC1—ocular cancer	0.000152	0.000448	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNA11—ocular cancer	0.000151	0.000448	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSPH—ocular cancer	0.000151	0.000446	CbGpPWpGaD
Zidovudine—ALB—Platelet degranulation—TGFB1—ocular cancer	0.000149	0.00044	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000146	0.000431	CbGpPWpGaD
Zidovudine—TERT—Disease—CDKN1A—ocular cancer	0.000144	0.000426	CbGpPWpGaD
Zidovudine—ALB—Folate Metabolism—TP53—ocular cancer	0.000143	0.000422	CbGpPWpGaD
Zidovudine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—ocular cancer	0.000142	0.000419	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—GNAQ—ocular cancer	0.000141	0.000416	CbGpPWpGaD
Zidovudine—TERT—Disease—EP300—ocular cancer	0.000137	0.000406	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN2B—ocular cancer	0.000136	0.000401	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSPH—ocular cancer	0.000136	0.0004	CbGpPWpGaD
Zidovudine—CYP2A6—NRF2 pathway—TGFB1—ocular cancer	0.000135	0.0004	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000133	0.000393	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSPH—ocular cancer	0.000132	0.000391	CbGpPWpGaD
Zidovudine—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000132	0.000389	CbGpPWpGaD
Zidovudine—TK1—Metabolism—EP300—ocular cancer	0.000127	0.000376	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—MDM2—ocular cancer	0.000126	0.000373	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000126	0.000372	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSPH—ocular cancer	0.000124	0.000365	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MDM2—ocular cancer	0.00012	0.000354	CbGpPWpGaD
Zidovudine—TERT—Disease—MYC—ocular cancer	0.00012	0.000353	CbGpPWpGaD
Zidovudine—TERT—Disease—TGFB1—ocular cancer	0.000119	0.000353	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—GNA11—ocular cancer	0.000117	0.000346	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNA11—ocular cancer	0.000112	0.00033	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CDKN1B—ocular cancer	0.000109	0.000323	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—GNAQ—ocular cancer	0.000109	0.000322	CbGpPWpGaD
Zidovudine—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000106	0.000312	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CCND1—ocular cancer	0.000104	0.000309	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—GNAQ—ocular cancer	0.000104	0.000307	CbGpPWpGaD
Zidovudine—ABCC4—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000101	0.0003	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—CDKN1A—ocular cancer	0.000101	0.000299	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HDAC1—ocular cancer	9.82e-05	0.00029	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—EP300—ocular cancer	9.61e-05	0.000284	CbGpPWpGaD
Zidovudine—TERT—Disease—HRAS—ocular cancer	9.4e-05	0.000278	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.33e-05	0.000276	CbGpPWpGaD
Zidovudine—SLC22A2—Transmission across Chemical Synapses—HRAS—ocular cancer	9.03e-05	0.000267	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—EP300—ocular cancer	8.65e-05	0.000256	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.52e-05	0.000252	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—MYC—ocular cancer	8.38e-05	0.000248	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TGFB1—ocular cancer	8.36e-05	0.000247	CbGpPWpGaD
Zidovudine—TERT—Disease—AKT1—ocular cancer	8.3e-05	0.000245	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSPH—ocular cancer	8.15e-05	0.000241	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.12e-05	0.00024	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	7.86e-05	0.000232	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNA11—ocular cancer	7.7e-05	0.000228	CbGpPWpGaD
Zidovudine—TK1—Metabolism—AKT1—ocular cancer	7.68e-05	0.000227	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNA11—ocular cancer	7.62e-05	0.000225	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MDM2—ocular cancer	7.54e-05	0.000223	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TGFB1—ocular cancer	7.52e-05	0.000222	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.48e-05	0.000221	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—GNAQ—ocular cancer	7.16e-05	0.000212	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—GNAQ—ocular cancer	7.08e-05	0.000209	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNA11—ocular cancer	7e-05	0.000207	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—CDK2—ocular cancer	6.97e-05	0.000206	CbGpPWpGaD
Zidovudine—SLC22A2—Neuronal System—HRAS—ocular cancer	6.92e-05	0.000204	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1B—ocular cancer	6.88e-05	0.000203	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—ocular cancer	6.88e-05	0.000203	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	6.6e-05	0.000195	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—HRAS—ocular cancer	6.58e-05	0.000194	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.52e-05	0.000193	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—GNAQ—ocular cancer	6.5e-05	0.000192	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.5e-05	0.000192	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1A—ocular cancer	6.35e-05	0.000188	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—ocular cancer	6.19e-05	0.000183	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EP300—ocular cancer	6.04e-05	0.000179	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—HRAS—ocular cancer	5.92e-05	0.000175	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—AKT1—ocular cancer	5.81e-05	0.000172	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.35e-05	0.000158	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—ocular cancer	5.27e-05	0.000156	CbGpPWpGaD
Zidovudine—ABCC5—Disease—TGFB1—ocular cancer	5.25e-05	0.000155	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—AKT1—ocular cancer	5.23e-05	0.000154	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—EP300—ocular cancer	5.06e-05	0.00015	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNA11—ocular cancer	4.78e-05	0.000141	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNA11—ocular cancer	4.75e-05	0.00014	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—AKT1—ocular cancer	4.59e-05	0.000136	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.52e-05	0.000134	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNAQ—ocular cancer	4.44e-05	0.000131	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNAQ—ocular cancer	4.42e-05	0.000131	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNA11—ocular cancer	4.27e-05	0.000126	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNA11—ocular cancer	4.16e-05	0.000123	CbGpPWpGaD
Zidovudine—ABCC5—Disease—HRAS—ocular cancer	4.14e-05	0.000122	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNAQ—ocular cancer	3.97e-05	0.000117	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EP300—ocular cancer	3.92e-05	0.000116	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNA11—ocular cancer	3.89e-05	0.000115	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNAQ—ocular cancer	3.87e-05	0.000114	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—ocular cancer	3.73e-05	0.00011	CbGpPWpGaD
Zidovudine—ABCC5—Disease—AKT1—ocular cancer	3.65e-05	0.000108	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNAQ—ocular cancer	3.62e-05	0.000107	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.58e-05	0.000106	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.56e-05	0.000105	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TGFB1—ocular cancer	3.4e-05	0.000101	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—ocular cancer	3.2e-05	9.45e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—AKT1—ocular cancer	3.06e-05	9.04e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	2.92e-05	8.62e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—ocular cancer	2.8e-05	8.28e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—HRAS—ocular cancer	2.68e-05	7.92e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—ocular cancer	2.57e-05	7.6e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNA11—ocular cancer	2.56e-05	7.58e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—ocular cancer	2.55e-05	7.52e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNAQ—ocular cancer	2.38e-05	7.05e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—AKT1—ocular cancer	2.37e-05	6.99e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—ocular cancer	2.34e-05	6.91e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—AKT1—ocular cancer	2.25e-05	6.66e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—ocular cancer	1.6e-05	4.72e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—ocular cancer	1.59e-05	4.69e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—AKT1—ocular cancer	1.55e-05	4.59e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—AKT1—ocular cancer	1.54e-05	4.55e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—ocular cancer	1.42e-05	4.21e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—AKT1—ocular cancer	1.41e-05	4.17e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—ocular cancer	1.39e-05	4.11e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—ocular cancer	1.3e-05	3.84e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—AKT1—ocular cancer	9.65e-06	2.85e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—AKT1—ocular cancer	9.59e-06	2.83e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—AKT1—ocular cancer	8.61e-06	2.54e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—ocular cancer	8.57e-06	2.53e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—AKT1—ocular cancer	8.4e-06	2.48e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—AKT1—ocular cancer	7.85e-06	2.32e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—AKT1—ocular cancer	5.18e-06	1.53e-05	CbGpPWpGaD
